Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Candel Therapeutics Inc (CADL)

Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Candel Therapeutics Inc 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 USA

www.candeltx.com Employees: 42 P: 617-916-5445

Description:

Candel Therapeutics Inc. is a late clinical stage biopharmaceutical company. It involved in developing novel oncolytic viral immunotherapies. The company's product pipeline includes CAN-2409 and CAN-3110. Candel Therapeutics Inc. is based in NEEDHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 284,165
Enterprise Value, $K 270,025
Shares Outstanding, K 32,476
Annual Sales, $ 0 K
Annual Net Income, $ -37,940 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,650 K
EBIT, $ -35,550 K
EBITDA, $ -34,590 K
60-Month Beta -0.95
% of Insider Shareholders 41.60%
% of Institutional Shareholders 13.93%
Float, K 18,966
% Float 58.40%
Short Volume Ratio 0.50

Growth:

1-Year Return 681.25%
3-Year Return 4.17%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.33 on 11/14/24
Next Earnings Date N/A
Earnings Per Share ttm -1.73
EPS Growth vs. Prev Qtr 55.41%
EPS Growth vs. Prev Year -13.79%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CADL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -629.29%
Return-on-Assets % -173.39%
Profit Margin % 0.00%
Debt/Equity -0.98
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.48
Interest Coverage -13.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar